2,834
Views
18
CrossRef citations to date
0
Altmetric
Research Article

An in vivo study of Hypericum perforatum in a niosomal topical drug delivery system

, , ORCID Icon, &
Pages 417-425 | Received 03 Nov 2017, Accepted 20 Jan 2018, Published online: 31 Jan 2018

References

  • Cecchini C, Cresci A, Coman MM, et al. (2007). Antimicrobial activity of seven Hypericum entities from central Italy. Planta Med 73:564–6.
  • Chen WC, Liou SS, Tzeng TF, et al. (2013). Effect of topical application of chlorogenic acid on excision wound healing in rats. Planta Med 79:616–21.
  • EMEA (European Medicines Agency). (2009). HMPC assessment report on Hypericum perforatum L., Herba. EMA/HMPC/101303/2008. London: EMEA.
  • Filippini R, Piovan A, Borsarini A, et al. (2010). Study of dynamic accumulation of secondary metabolites in three subspecies of Hypericum perforatum. Fitoterapia 81:115–9.
  • German Pharmacopoeia. (2014). EB6 (Deutsches Arzneibuch. Suppl., 6th edition), (2014). Bonn: Phytopharmaceutical Corporation; 1941: 409.
  • Ghaisas MM, Kshirsagar SB, Sahane RS. (2014). Evaluation of wound healing activity of ferulic acid in diabetic rats. Int Wound J 11:523–32.
  • Handa T, Takeuchi H, Ohokubo Y, et al. (1987). Lyophilized liposomes prepared by a modified reversed-phase evaporation method. Chem Pharm Bull 35:748–55.
  • Isacchi B, Bergonzi MC, Carnevali F, et al. (2007). Analysis and stability of the constituents of St. John’s wort oils prepared with different methods. J Pharm Biomed Anal 45:756–61.
  • Koeberle A, Rossi A, Bauer J, et al. (2011). Hyperforin, an anti-inflammatory constituent from St. John’s Wort, Inhibits Microsomal Prostaglandin E(2) Synthase-1 and Suppresses Prostaglandin E(2) Formation in vivo. Front Pharmacol 2:7.
  • Miraldi E, Biagi M, Giachetti D. (2006). Chemical constituents and effects of topical application of Oleum Hyperici on skin sensitivity to simulated sun exposure. Nat Prod Commun 1:209–13.
  • Moghassemi S, Hadjizadeh A. (2014). Nano-niosomes as nanoscale drug delivery systems: an illustrated review. J Control Release 185:22–36.
  • Öztürk N, Korkmaz S, Öztürk Y. (2007). Wound-healing activity of St. John’s Wort (Hypericum perforatum L.) on chicken embryonic fibroblasts. J Ethnopharmacol 111:33–9.
  • Purasa G, Mashala M, Záratea J, et al. (2013). A novel cationic niosome formulation for gene delivery to the retina. J Control Release 174:27–36.
  • Rafiee-Tehrani M, Mehramizi A. (2000). In vitro release studies of Piroxicam from oil-in-water creams and hydroalcoholic gel topical formulations. Drug Dev Ind Pharm 26:409–14.
  • Rainha N, Lima E, Baptista J. (2011). Comparison of the endemic Azorean Hypericum foliosum with other Hypericum species: antioxidant activity and phenolic profile. Nat Prod Res 25:123–35.
  • Ruckmani K, Sankar V. (2010). Formulation and optimization of Zidovudine niosomes. AAPS PharmSciTech 11:1119–27.
  • Schempp CM, Lüdtke R, Winghofer B, et al. (2000). Effect of topical application of Hypericum perforatum extract (St. John’s wort) on skin sensitivity to solar simulated radiation. Photodermatol Photoimmunol Photomed 16:125–8.
  • Schempp CM, Windeck T, Hezel S, et al. (2003). Topical treatment of atopic dermatitis with St. John’s wort cream – a randomized, placebo controlled, double blind half-side comparison. Phytomedicine 10:31–7.
  • Süntar IP, Akkol EK, Yılmazer D, et al. (2010). Investigations on the in vivo wound healing potential of Hypericum perforatum L. J Ethnopharmacol 127:468–77.
  • Tawaha K, Gharaibeh M, El-Elimat T, et al. (2010). Determination of hypericin and hyperforin content in selected Jordanian Hypericum species. Ind Crop Prod 32:241–5.
  • WHO. (2002). WHO-monographs on selected medical plants. Geneva: World Health Organization.
  • Wölfle U, Seelinger G, Schempp CM. (2014). Topical application of St. John’s wort (Hypericum perforatum). Planta Med 80:109–20.